CDKN2B and laryngotracheoesophageal cleft: In our in vitro assay, after silencing of CDKN2B-AS1, LC cells presented substantially enhanced apoptotic activity and substantially suppressed invasion, proliferation, as well as migration, suggesting the oncogene role of overexpressed CDKN2B-AS1 in LC and its potential to be the therapeutic target.